Who
New Enterprise Associates 17, L.P.
10% owner
Company insider
Files Form 4 as: 10% owner, Korro Bio; 10% owner, SpyGlass Pharma; 10% owner, NeueHealth.
In numbers
- Trades disclosed
- 14
- Buys
- 2
- Sells
- 0
- Bought
- $19.6M
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 8 Apr 2024
- Last trade
- 10 Mar 2026
- Last filed
- 12 Mar 2026
Companies traded
Activity over time
1 Feb – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Mar 2026filed 12 Mar 2026 | KRRO Korro BioBiotechnology | SEC FORM 4 Bought | $2.3M207,100 at $11.11 | filing |
| 10 Mar 2026filed 12 Mar 2026 | KRRO Korro Biooption or derivative · Biotechnology | SEC FORM 4 Code P | $2.7M242,945 at $11.11 | filing |
| 10 Mar 2026filed 12 Mar 2026 | KRRO Korro Biooption or derivative · Biotechnology | SEC FORM 4 Code P | $2.7M242,945 at $11.11 | filing |
| 10 Mar 2026filed 12 Mar 2026 | KRRO Korro BioBiotechnology | SEC FORM 4 Bought | $2.3M207,100 at $11.11 | filing |
| 9 Feb 2026filed 11 Feb 2026 | SGP SpyGlass PharmaMedical Devices | SEC FORM 4 Code C | —1,619,240 | filing |
| 9 Feb 2026filed 11 Feb 2026 | SGP SpyGlass PharmaMedical Devices | SEC FORM 4 Code C | —1,370,168 | filing |
| 9 Feb 2026filed 11 Feb 2026 | SGP SpyGlass PharmaMedical Devices | SEC FORM 4 Code C | —1,370,168 | filing |
| 9 Feb 2026filed 11 Feb 2026 | SGP SpyGlass PharmaMedical Devices | SEC FORM 4 Code C | —737,962 | filing |
| 9 Feb 2026filed 11 Feb 2026 | SGP SpyGlass PharmaMedical Devices | SEC FORM 4 Bought | $15.0M937,500 at $16.00 | filing |
| 9 Feb 2026filed 11 Feb 2026 | SGP SpyGlass Pharmaoption or derivative · Medical Devices | SEC FORM 4 Code C | —1,619,240 | filing |
| 9 Feb 2026filed 11 Feb 2026 | SGP SpyGlass Pharmaoption or derivative · Medical Devices | SEC FORM 4 Code C | —1,370,168 | filing |
| 9 Feb 2026filed 11 Feb 2026 | SGP SpyGlass Pharmaoption or derivative · Medical Devices | SEC FORM 4 Code C | —1,370,168 | filing |
| 9 Feb 2026filed 11 Feb 2026 | SGP SpyGlass Pharmaoption or derivative · Medical Devices | SEC FORM 4 Code C | —737,962 | filing |
| 8 Apr 2024filed 10 Apr 2024 | NeueHealthoption or derivative | SEC FORM 4 Code P | —123,729 | filing |
News
SpyGlass Pharma Announces Positive 4-Year Data From First-in-Human Trial of Its Innovative BIM-IOL SystemSGP · manilatimes.net · 19 Oct 2026BioLineRx (NASDAQ:BLRX) and Korro Bio (NASDAQ:KRRO) Head to Head SurveyKRRO · dailypolitical.com · 14 Oct 2026Contrasting BioLineRx (NASDAQ:BLRX) & Korro Bio (NASDAQ:KRRO)KRRO · tickerreport.com · 14 Oct 2026Korro Bio Doses First Cohort In Phase 1/2 Study Of KRRO-121 For HyperammonemiaKRRO · rttnews.com · 7 Oct 2026
0 headlines in the last 90 days name New Enterprise Associates 17, L.P.; 4 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.